Aims and Objectives
Infections in the intensive care unit (ICU) represent the nosocomial infections of the near future as it is predicted that hospitals of the future will be transformed into massive ICUs and other units providing increased levels of care. Generally, patients who are transferred from the ICU to hospital wards are colonised with antimicrobial-resistant bacteria, providing a focus for spread and colonization of the whole hospital. Thus, today’s ICUs are of major concern regarding both prevention and therapy of the nosocomial infections arising in their environment. Ventilation associated pneumonia (VAP) and central catheter-associated infections represent the majority of ICU infections, with mortality rates exceeding 30%. The principle causes are multi-resistant strains of Pseudomonas aeruginosa, Acinetobacter baumannii, Klebsiella species producing ESBLs, MRSA and VRE strains.
This Working Group aims to:
- Enhance the epidemiological surveillance of nosocomial ICU infections
- Promote antibiotic resistant surveillance in ICUs
- Evaluate therapeutic decisions in the ICU. These include antibiotic rotation, restriction and de-escalation policies, in order to prevent and/or reduce resistance rates by applying well-organised protocols
- Evaluate the validity of surveillance cultures as a guide to empirical antimicrobial therapy
- Promote the implementation of “hand-hygiene protocols”.